Skip to main content
Log in

Tolerability of high doses of (−)-moprolol in healthy volunteers

  • Letter To The Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Howe R, Shanks RG (1966) Optical isomers of propranolol. Nature 210: 1336

    Google Scholar 

  • Ghirardi P, Grosso G (1980) Antihypertensive activity of (−)-Moprolol in man: double-blind comparison of enantiomers. J Cardiovasc Pharmacol 2: 471

    Google Scholar 

  • Hartley HO (1962) In: Ralston A, Wilf H (eds) Mathematical Methods for digital computers, John Willy, New York, Chap 20

    Google Scholar 

  • Kirk RE (1968) Experimental design: procedures for the behavioral sciences. Brooks-Cole, Belmont, California. Chapt 7: Completely randomized, hierarchal, and randomized block factorial designs pp 171. Chapt 5: Randomized block design, pp 131

  • Höffkes H (1981) (−)-Moprolol once a day in hypertensive out-patients. Curr Ther Res 30: 88

    Google Scholar 

  • Nicaise J, Desmedt J, Kunstler M, Vryens R, Wuestenberghs A (1981) (−)-Moprolol as antihypertensive therapy in the elderly. Curr Ther Res 30: 93

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Triulzi, M.O., Balice, G., Gentile, F. et al. Tolerability of high doses of (−)-moprolol in healthy volunteers. Eur J Clin Pharmacol 22, 377–378 (1982). https://doi.org/10.1007/BF00548409

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00548409

Keywords

Navigation